Global Pan-cancer Genetic Testing Market Research Report 2026(Status and Outlook)
Pan-cancer genetic testing is a technique used to detect mutations or alterations in genes associated with various types of cancer. By analyzing an individual?s genomic information, it can identify genetic variations linked to different cancers (such as lung, breast, colorectal cancers, etc.), providing critical insights for early diagnosis, personalized treatment, and prognostic assessment.
The global Pan-cancer Genetic Testing market size was estimated at USD 4969.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pan-cancer Genetic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pan-cancer Genetic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pan-cancer Genetic Testing market.
Global Pan-cancer Genetic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Eurofins Scientific
Natera
Shenzhen BGI
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Beijing Novogene Technology
Genotypic Technology
Dna Link
Burning Rock Medicine
Science and Gene
Market Segmentation (by Type)
NGS Testing
Other Testing
Market Segmentation (by Application)
Hospitals and Clinics
Biopharmaceutical Companies
Academic Research Institutions
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pan-cancer Genetic Testing Market
Overview of the regional outlook of the Pan-cancer Genetic Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pan-cancer Genetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pan-cancer Genetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pan-cancer Genetic Testing market size was estimated at USD 4969.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pan-cancer Genetic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pan-cancer Genetic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pan-cancer Genetic Testing market.
Global Pan-cancer Genetic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Eurofins Scientific
Natera
Shenzhen BGI
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Beijing Novogene Technology
Genotypic Technology
Dna Link
Burning Rock Medicine
Science and Gene
Market Segmentation (by Type)
NGS Testing
Other Testing
Market Segmentation (by Application)
Hospitals and Clinics
Biopharmaceutical Companies
Academic Research Institutions
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pan-cancer Genetic Testing Market
Overview of the regional outlook of the Pan-cancer Genetic Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pan-cancer Genetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pan-cancer Genetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pan-cancer Genetic Testing
1.2 Key Market Segments
1.2.1 Pan-cancer Genetic Testing Segment by Type
1.2.2 Pan-cancer Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PAN-CANCER GENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PAN-CANCER GENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pan-cancer Genetic Testing Product Life Cycle
3.3 Global Pan-cancer Genetic Testing Revenue Market Share by Company (2020-2025)
3.4 Pan-cancer Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Pan-cancer Genetic Testing Market Competitive Situation and Trends
3.6.1 Pan-cancer Genetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pan-cancer Genetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PAN-CANCER GENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Pan-cancer Genetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PAN-CANCER GENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pan-cancer Genetic Testing Market Porter's Five Forces Analysis
6 PAN-CANCER GENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pan-cancer Genetic Testing Market by Type (2020-2025)
6.3 Global Pan-cancer Genetic Testing Market Size Growth Rate by Type (2021-2025)
7 PAN-CANCER GENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pan-cancer Genetic Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Pan-cancer Genetic Testing Market Size Growth Rate by Application (2021-2025)
8 PAN-CANCER GENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Pan-cancer Genetic Testing Market Size by Region
8.1.1 Global Pan-cancer Genetic Testing Market Size by Region
8.1.2 Global Pan-cancer Genetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Pan-cancer Genetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pan-cancer Genetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Pan-cancer Genetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pan-cancer Genetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pan-cancer Genetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina Basic Information
9.1.2 Illumina Pan-cancer Genetic Testing Product Overview
9.1.3 Illumina Pan-cancer Genetic Testing Product Market Performance
9.1.4 Illumina SWOT Analysis
9.1.5 Illumina Business Overview
9.1.6 Illumina Recent Developments
9.2 Eurofins Scientific
9.2.1 Eurofins Scientific Basic Information
9.2.2 Eurofins Scientific Pan-cancer Genetic Testing Product Overview
9.2.3 Eurofins Scientific Pan-cancer Genetic Testing Product Market Performance
9.2.4 Eurofins Scientific SWOT Analysis
9.2.5 Eurofins Scientific Business Overview
9.2.6 Eurofins Scientific Recent Developments
9.3 Natera
9.3.1 Natera Basic Information
9.3.2 Natera Pan-cancer Genetic Testing Product Overview
9.3.3 Natera Pan-cancer Genetic Testing Product Market Performance
9.3.4 Natera SWOT Analysis
9.3.5 Natera Business Overview
9.3.6 Natera Recent Developments
9.4 Shenzhen BGI
9.4.1 Shenzhen BGI Basic Information
9.4.2 Shenzhen BGI Pan-cancer Genetic Testing Product Overview
9.4.3 Shenzhen BGI Pan-cancer Genetic Testing Product Market Performance
9.4.4 Shenzhen BGI Business Overview
9.4.5 Shenzhen BGI Recent Developments
9.5 Roche
9.5.1 Roche Basic Information
9.5.2 Roche Pan-cancer Genetic Testing Product Overview
9.5.3 Roche Pan-cancer Genetic Testing Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 LabCorp
9.6.1 LabCorp Basic Information
9.6.2 LabCorp Pan-cancer Genetic Testing Product Overview
9.6.3 LabCorp Pan-cancer Genetic Testing Product Market Performance
9.6.4 LabCorp Business Overview
9.6.5 LabCorp Recent Developments
9.7 Berry Genomics
9.7.1 Berry Genomics Basic Information
9.7.2 Berry Genomics Pan-cancer Genetic Testing Product Overview
9.7.3 Berry Genomics Pan-cancer Genetic Testing Product Market Performance
9.7.4 Berry Genomics Business Overview
9.7.5 Berry Genomics Recent Developments
9.8 Brooks Life Sciences
9.8.1 Brooks Life Sciences Basic Information
9.8.2 Brooks Life Sciences Pan-cancer Genetic Testing Product Overview
9.8.3 Brooks Life Sciences Pan-cancer Genetic Testing Product Market Performance
9.8.4 Brooks Life Sciences Business Overview
9.8.5 Brooks Life Sciences Recent Developments
9.9 Macrogen
9.9.1 Macrogen Basic Information
9.9.2 Macrogen Pan-cancer Genetic Testing Product Overview
9.9.3 Macrogen Pan-cancer Genetic Testing Product Market Performance
9.9.4 Macrogen Business Overview
9.9.5 Macrogen Recent Developments
9.10 Personalis
9.10.1 Personalis Basic Information
9.10.2 Personalis Pan-cancer Genetic Testing Product Overview
9.10.3 Personalis Pan-cancer Genetic Testing Product Market Performance
9.10.4 Personalis Business Overview
9.10.5 Personalis Recent Developments
9.11 Beijing Novogene Technology
9.11.1 Beijing Novogene Technology Basic Information
9.11.2 Beijing Novogene Technology Pan-cancer Genetic Testing Product Overview
9.11.3 Beijing Novogene Technology Pan-cancer Genetic Testing Product Market Performance
9.11.4 Beijing Novogene Technology Business Overview
9.11.5 Beijing Novogene Technology Recent Developments
9.12 Genotypic Technology
9.12.1 Genotypic Technology Basic Information
9.12.2 Genotypic Technology Pan-cancer Genetic Testing Product Overview
9.12.3 Genotypic Technology Pan-cancer Genetic Testing Product Market Performance
9.12.4 Genotypic Technology Business Overview
9.12.5 Genotypic Technology Recent Developments
9.13 Dna Link
9.13.1 Dna Link Basic Information
9.13.2 Dna Link Pan-cancer Genetic Testing Product Overview
9.13.3 Dna Link Pan-cancer Genetic Testing Product Market Performance
9.13.4 Dna Link Business Overview
9.13.5 Dna Link Recent Developments
9.14 Burning Rock Medicine
9.14.1 Burning Rock Medicine Basic Information
9.14.2 Burning Rock Medicine Pan-cancer Genetic Testing Product Overview
9.14.3 Burning Rock Medicine Pan-cancer Genetic Testing Product Market Performance
9.14.4 Burning Rock Medicine Business Overview
9.14.5 Burning Rock Medicine Recent Developments
9.15 Science and Gene
9.15.1 Science and Gene Basic Information
9.15.2 Science and Gene Pan-cancer Genetic Testing Product Overview
9.15.3 Science and Gene Pan-cancer Genetic Testing Product Market Performance
9.15.4 Science and Gene Business Overview
9.15.5 Science and Gene Recent Developments
10 PAN-CANCER GENETIC TESTING MARKET FORECAST BY REGION
10.1 Global Pan-cancer Genetic Testing Market Size Forecast
10.2 Global Pan-cancer Genetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pan-cancer Genetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Pan-cancer Genetic Testing Market Size Forecast by Region
10.2.4 South America Pan-cancer Genetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Pan-cancer Genetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Pan-cancer Genetic Testing Market Forecast by Type (2026-2035)
11.1.1 Global Pan-cancer Genetic Testing Market Size Forecast by Type (2026-2035)
11.2 Global Pan-cancer Genetic Testing Market Forecast by Application (2026-2035)
11.2.1 Global Pan-cancer Genetic Testing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pan-cancer Genetic Testing
1.2 Key Market Segments
1.2.1 Pan-cancer Genetic Testing Segment by Type
1.2.2 Pan-cancer Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PAN-CANCER GENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PAN-CANCER GENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pan-cancer Genetic Testing Product Life Cycle
3.3 Global Pan-cancer Genetic Testing Revenue Market Share by Company (2020-2025)
3.4 Pan-cancer Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Pan-cancer Genetic Testing Market Competitive Situation and Trends
3.6.1 Pan-cancer Genetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pan-cancer Genetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PAN-CANCER GENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Pan-cancer Genetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PAN-CANCER GENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pan-cancer Genetic Testing Market Porter's Five Forces Analysis
6 PAN-CANCER GENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pan-cancer Genetic Testing Market by Type (2020-2025)
6.3 Global Pan-cancer Genetic Testing Market Size Growth Rate by Type (2021-2025)
7 PAN-CANCER GENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pan-cancer Genetic Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Pan-cancer Genetic Testing Market Size Growth Rate by Application (2021-2025)
8 PAN-CANCER GENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Pan-cancer Genetic Testing Market Size by Region
8.1.1 Global Pan-cancer Genetic Testing Market Size by Region
8.1.2 Global Pan-cancer Genetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Pan-cancer Genetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pan-cancer Genetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Pan-cancer Genetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pan-cancer Genetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pan-cancer Genetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina Basic Information
9.1.2 Illumina Pan-cancer Genetic Testing Product Overview
9.1.3 Illumina Pan-cancer Genetic Testing Product Market Performance
9.1.4 Illumina SWOT Analysis
9.1.5 Illumina Business Overview
9.1.6 Illumina Recent Developments
9.2 Eurofins Scientific
9.2.1 Eurofins Scientific Basic Information
9.2.2 Eurofins Scientific Pan-cancer Genetic Testing Product Overview
9.2.3 Eurofins Scientific Pan-cancer Genetic Testing Product Market Performance
9.2.4 Eurofins Scientific SWOT Analysis
9.2.5 Eurofins Scientific Business Overview
9.2.6 Eurofins Scientific Recent Developments
9.3 Natera
9.3.1 Natera Basic Information
9.3.2 Natera Pan-cancer Genetic Testing Product Overview
9.3.3 Natera Pan-cancer Genetic Testing Product Market Performance
9.3.4 Natera SWOT Analysis
9.3.5 Natera Business Overview
9.3.6 Natera Recent Developments
9.4 Shenzhen BGI
9.4.1 Shenzhen BGI Basic Information
9.4.2 Shenzhen BGI Pan-cancer Genetic Testing Product Overview
9.4.3 Shenzhen BGI Pan-cancer Genetic Testing Product Market Performance
9.4.4 Shenzhen BGI Business Overview
9.4.5 Shenzhen BGI Recent Developments
9.5 Roche
9.5.1 Roche Basic Information
9.5.2 Roche Pan-cancer Genetic Testing Product Overview
9.5.3 Roche Pan-cancer Genetic Testing Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 LabCorp
9.6.1 LabCorp Basic Information
9.6.2 LabCorp Pan-cancer Genetic Testing Product Overview
9.6.3 LabCorp Pan-cancer Genetic Testing Product Market Performance
9.6.4 LabCorp Business Overview
9.6.5 LabCorp Recent Developments
9.7 Berry Genomics
9.7.1 Berry Genomics Basic Information
9.7.2 Berry Genomics Pan-cancer Genetic Testing Product Overview
9.7.3 Berry Genomics Pan-cancer Genetic Testing Product Market Performance
9.7.4 Berry Genomics Business Overview
9.7.5 Berry Genomics Recent Developments
9.8 Brooks Life Sciences
9.8.1 Brooks Life Sciences Basic Information
9.8.2 Brooks Life Sciences Pan-cancer Genetic Testing Product Overview
9.8.3 Brooks Life Sciences Pan-cancer Genetic Testing Product Market Performance
9.8.4 Brooks Life Sciences Business Overview
9.8.5 Brooks Life Sciences Recent Developments
9.9 Macrogen
9.9.1 Macrogen Basic Information
9.9.2 Macrogen Pan-cancer Genetic Testing Product Overview
9.9.3 Macrogen Pan-cancer Genetic Testing Product Market Performance
9.9.4 Macrogen Business Overview
9.9.5 Macrogen Recent Developments
9.10 Personalis
9.10.1 Personalis Basic Information
9.10.2 Personalis Pan-cancer Genetic Testing Product Overview
9.10.3 Personalis Pan-cancer Genetic Testing Product Market Performance
9.10.4 Personalis Business Overview
9.10.5 Personalis Recent Developments
9.11 Beijing Novogene Technology
9.11.1 Beijing Novogene Technology Basic Information
9.11.2 Beijing Novogene Technology Pan-cancer Genetic Testing Product Overview
9.11.3 Beijing Novogene Technology Pan-cancer Genetic Testing Product Market Performance
9.11.4 Beijing Novogene Technology Business Overview
9.11.5 Beijing Novogene Technology Recent Developments
9.12 Genotypic Technology
9.12.1 Genotypic Technology Basic Information
9.12.2 Genotypic Technology Pan-cancer Genetic Testing Product Overview
9.12.3 Genotypic Technology Pan-cancer Genetic Testing Product Market Performance
9.12.4 Genotypic Technology Business Overview
9.12.5 Genotypic Technology Recent Developments
9.13 Dna Link
9.13.1 Dna Link Basic Information
9.13.2 Dna Link Pan-cancer Genetic Testing Product Overview
9.13.3 Dna Link Pan-cancer Genetic Testing Product Market Performance
9.13.4 Dna Link Business Overview
9.13.5 Dna Link Recent Developments
9.14 Burning Rock Medicine
9.14.1 Burning Rock Medicine Basic Information
9.14.2 Burning Rock Medicine Pan-cancer Genetic Testing Product Overview
9.14.3 Burning Rock Medicine Pan-cancer Genetic Testing Product Market Performance
9.14.4 Burning Rock Medicine Business Overview
9.14.5 Burning Rock Medicine Recent Developments
9.15 Science and Gene
9.15.1 Science and Gene Basic Information
9.15.2 Science and Gene Pan-cancer Genetic Testing Product Overview
9.15.3 Science and Gene Pan-cancer Genetic Testing Product Market Performance
9.15.4 Science and Gene Business Overview
9.15.5 Science and Gene Recent Developments
10 PAN-CANCER GENETIC TESTING MARKET FORECAST BY REGION
10.1 Global Pan-cancer Genetic Testing Market Size Forecast
10.2 Global Pan-cancer Genetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pan-cancer Genetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Pan-cancer Genetic Testing Market Size Forecast by Region
10.2.4 South America Pan-cancer Genetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Pan-cancer Genetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Pan-cancer Genetic Testing Market Forecast by Type (2026-2035)
11.1.1 Global Pan-cancer Genetic Testing Market Size Forecast by Type (2026-2035)
11.2 Global Pan-cancer Genetic Testing Market Forecast by Application (2026-2035)
11.2.1 Global Pan-cancer Genetic Testing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pan-cancer Genetic Testing Market Size by Type (M USD)
Table 4. Global Pan-cancer Genetic Testing Market Size by Application
Table 5. Pan-cancer Genetic Testing Market Size Comparison by Region (M USD)
Table 6. Global Pan-cancer Genetic Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Pan-cancer Genetic Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pan-cancer Genetic Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Pan-cancer Genetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Pan-cancer Genetic Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Pan-cancer Genetic Testing Market Size by Type (M USD)
Table 22. Global Pan-cancer Genetic Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Pan-cancer Genetic Testing Market Share by Type (2020-2025)
Table 24. Global Pan-cancer Genetic Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Pan-cancer Genetic Testing Market Size by Application
Table 26. Global Pan-cancer Genetic Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Pan-cancer Genetic Testing Market Share by Application (2020-2025)
Table 28. Global Pan-cancer Genetic Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Pan-cancer Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Pan-cancer Genetic Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Pan-cancer Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Pan-cancer Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 36. Illumina Basic Information
Table 37. Illumina Pan-cancer Genetic Testing Product Overview
Table 38. Illumina Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Illumina SWOT Analysis
Table 40. Illumina Business Overview
Table 41. Illumina Recent Developments
Table 42. Eurofins Scientific Basic Information
Table 43. Eurofins Scientific Pan-cancer Genetic Testing Product Overview
Table 44. Eurofins Scientific Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Eurofins Scientific SWOT Analysis
Table 46. Eurofins Scientific Business Overview
Table 47. Eurofins Scientific Recent Developments
Table 48. Natera Basic Information
Table 49. Natera Pan-cancer Genetic Testing Product Overview
Table 50. Natera Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Natera SWOT Analysis
Table 52. Natera Business Overview
Table 53. Natera Recent Developments
Table 54. Shenzhen BGI Basic Information
Table 55. Shenzhen BGI Pan-cancer Genetic Testing Product Overview
Table 56. Shenzhen BGI Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Shenzhen BGI Business Overview
Table 58. Shenzhen BGI Recent Developments
Table 59. Roche Basic Information
Table 60. Roche Pan-cancer Genetic Testing Product Overview
Table 61. Roche Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Roche Business Overview
Table 63. Roche Recent Developments
Table 64. LabCorp Basic Information
Table 65. LabCorp Pan-cancer Genetic Testing Product Overview
Table 66. LabCorp Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. LabCorp Business Overview
Table 68. LabCorp Recent Developments
Table 69. Berry Genomics Basic Information
Table 70. Berry Genomics Pan-cancer Genetic Testing Product Overview
Table 71. Berry Genomics Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Berry Genomics Business Overview
Table 73. Berry Genomics Recent Developments
Table 74. Brooks Life Sciences Basic Information
Table 75. Brooks Life Sciences Pan-cancer Genetic Testing Product Overview
Table 76. Brooks Life Sciences Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Brooks Life Sciences Business Overview
Table 78. Brooks Life Sciences Recent Developments
Table 79. Macrogen Basic Information
Table 80. Macrogen Pan-cancer Genetic Testing Product Overview
Table 81. Macrogen Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Macrogen Business Overview
Table 83. Macrogen Recent Developments
Table 84. Personalis Basic Information
Table 85. Personalis Pan-cancer Genetic Testing Product Overview
Table 86. Personalis Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Personalis Business Overview
Table 88. Personalis Recent Developments
Table 89. Beijing Novogene Technology Basic Information
Table 90. Beijing Novogene Technology Pan-cancer Genetic Testing Product Overview
Table 91. Beijing Novogene Technology Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Beijing Novogene Technology Business Overview
Table 93. Beijing Novogene Technology Recent Developments
Table 94. Genotypic Technology Basic Information
Table 95. Genotypic Technology Pan-cancer Genetic Testing Product Overview
Table 96. Genotypic Technology Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Genotypic Technology Business Overview
Table 98. Genotypic Technology Recent Developments
Table 99. Dna Link Basic Information
Table 100. Dna Link Pan-cancer Genetic Testing Product Overview
Table 101. Dna Link Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Dna Link Business Overview
Table 103. Dna Link Recent Developments
Table 104. Burning Rock Medicine Basic Information
Table 105. Burning Rock Medicine Pan-cancer Genetic Testing Product Overview
Table 106. Burning Rock Medicine Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Burning Rock Medicine Business Overview
Table 108. Burning Rock Medicine Recent Developments
Table 109. Science and Gene Basic Information
Table 110. Science and Gene Pan-cancer Genetic Testing Product Overview
Table 111. Science and Gene Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Science and Gene Business Overview
Table 113. Science and Gene Recent Developments
Table 114. Global Pan-cancer Genetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 115. North America Pan-cancer Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Europe Pan-cancer Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Asia Pacific Pan-cancer Genetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Pan-cancer Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Middle East and Africa Pan-cancer Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Global Pan-cancer Genetic Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 121. Global Pan-cancer Genetic Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pan-cancer Genetic Testing Market Size by Type (M USD)
Table 4. Global Pan-cancer Genetic Testing Market Size by Application
Table 5. Pan-cancer Genetic Testing Market Size Comparison by Region (M USD)
Table 6. Global Pan-cancer Genetic Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Pan-cancer Genetic Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pan-cancer Genetic Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Pan-cancer Genetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Pan-cancer Genetic Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Pan-cancer Genetic Testing Market Size by Type (M USD)
Table 22. Global Pan-cancer Genetic Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Pan-cancer Genetic Testing Market Share by Type (2020-2025)
Table 24. Global Pan-cancer Genetic Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Pan-cancer Genetic Testing Market Size by Application
Table 26. Global Pan-cancer Genetic Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Pan-cancer Genetic Testing Market Share by Application (2020-2025)
Table 28. Global Pan-cancer Genetic Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Pan-cancer Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Pan-cancer Genetic Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Pan-cancer Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Pan-cancer Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 36. Illumina Basic Information
Table 37. Illumina Pan-cancer Genetic Testing Product Overview
Table 38. Illumina Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Illumina SWOT Analysis
Table 40. Illumina Business Overview
Table 41. Illumina Recent Developments
Table 42. Eurofins Scientific Basic Information
Table 43. Eurofins Scientific Pan-cancer Genetic Testing Product Overview
Table 44. Eurofins Scientific Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Eurofins Scientific SWOT Analysis
Table 46. Eurofins Scientific Business Overview
Table 47. Eurofins Scientific Recent Developments
Table 48. Natera Basic Information
Table 49. Natera Pan-cancer Genetic Testing Product Overview
Table 50. Natera Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Natera SWOT Analysis
Table 52. Natera Business Overview
Table 53. Natera Recent Developments
Table 54. Shenzhen BGI Basic Information
Table 55. Shenzhen BGI Pan-cancer Genetic Testing Product Overview
Table 56. Shenzhen BGI Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Shenzhen BGI Business Overview
Table 58. Shenzhen BGI Recent Developments
Table 59. Roche Basic Information
Table 60. Roche Pan-cancer Genetic Testing Product Overview
Table 61. Roche Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Roche Business Overview
Table 63. Roche Recent Developments
Table 64. LabCorp Basic Information
Table 65. LabCorp Pan-cancer Genetic Testing Product Overview
Table 66. LabCorp Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. LabCorp Business Overview
Table 68. LabCorp Recent Developments
Table 69. Berry Genomics Basic Information
Table 70. Berry Genomics Pan-cancer Genetic Testing Product Overview
Table 71. Berry Genomics Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Berry Genomics Business Overview
Table 73. Berry Genomics Recent Developments
Table 74. Brooks Life Sciences Basic Information
Table 75. Brooks Life Sciences Pan-cancer Genetic Testing Product Overview
Table 76. Brooks Life Sciences Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Brooks Life Sciences Business Overview
Table 78. Brooks Life Sciences Recent Developments
Table 79. Macrogen Basic Information
Table 80. Macrogen Pan-cancer Genetic Testing Product Overview
Table 81. Macrogen Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Macrogen Business Overview
Table 83. Macrogen Recent Developments
Table 84. Personalis Basic Information
Table 85. Personalis Pan-cancer Genetic Testing Product Overview
Table 86. Personalis Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Personalis Business Overview
Table 88. Personalis Recent Developments
Table 89. Beijing Novogene Technology Basic Information
Table 90. Beijing Novogene Technology Pan-cancer Genetic Testing Product Overview
Table 91. Beijing Novogene Technology Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Beijing Novogene Technology Business Overview
Table 93. Beijing Novogene Technology Recent Developments
Table 94. Genotypic Technology Basic Information
Table 95. Genotypic Technology Pan-cancer Genetic Testing Product Overview
Table 96. Genotypic Technology Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Genotypic Technology Business Overview
Table 98. Genotypic Technology Recent Developments
Table 99. Dna Link Basic Information
Table 100. Dna Link Pan-cancer Genetic Testing Product Overview
Table 101. Dna Link Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Dna Link Business Overview
Table 103. Dna Link Recent Developments
Table 104. Burning Rock Medicine Basic Information
Table 105. Burning Rock Medicine Pan-cancer Genetic Testing Product Overview
Table 106. Burning Rock Medicine Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Burning Rock Medicine Business Overview
Table 108. Burning Rock Medicine Recent Developments
Table 109. Science and Gene Basic Information
Table 110. Science and Gene Pan-cancer Genetic Testing Product Overview
Table 111. Science and Gene Pan-cancer Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Science and Gene Business Overview
Table 113. Science and Gene Recent Developments
Table 114. Global Pan-cancer Genetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 115. North America Pan-cancer Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Europe Pan-cancer Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Asia Pacific Pan-cancer Genetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Pan-cancer Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Middle East and Africa Pan-cancer Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Global Pan-cancer Genetic Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 121. Global Pan-cancer Genetic Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Pan-cancer Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pan-cancer Genetic Testing Market Size (M USD), 2025-2035
Figure 5. Global Pan-cancer Genetic Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Pan-cancer Genetic Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Pan-cancer Genetic Testing Product Life Cycle
Figure 12. Global Pan-cancer Genetic Testing Revenue Share by Company in 2025
Figure 13. Pan-cancer Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Pan-cancer Genetic Testing Revenue in 2025
Figure 15. Value Chain Map of Pan-cancer Genetic Testing
Figure 16. Global Pan-cancer Genetic Testing Market PEST Analysis
Figure 17. Global Pan-cancer Genetic Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Pan-cancer Genetic Testing Market Share by Type
Figure 20. Market Share of Pan-cancer Genetic Testing by Type (2020-2025)
Figure 21. Global Pan-cancer Genetic Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pan-cancer Genetic Testing Market Share by Application
Figure 24. Global Pan-cancer Genetic Testing Market Share by Application (2020-2025)
Figure 25. Global Pan-cancer Genetic Testing Market Share by Application in 2024
Figure 26. Global Pan-cancer Genetic Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Pan-cancer Genetic Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Pan-cancer Genetic Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Pan-cancer Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Pan-cancer Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Pan-cancer Genetic Testing Market Share by Country in 2024
Figure 35. Germany Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Pan-cancer Genetic Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Pan-cancer Genetic Testing Market Size Market Share by Region in 2024
Figure 42. China Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Pan-cancer Genetic Testing Market Size and Growth Rate (M USD)
Figure 48. South America Pan-cancer Genetic Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Pan-cancer Genetic Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Pan-cancer Genetic Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Pan-cancer Genetic Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Pan-cancer Genetic Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Pan-cancer Genetic Testing Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Pan-cancer Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pan-cancer Genetic Testing Market Size (M USD), 2025-2035
Figure 5. Global Pan-cancer Genetic Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Pan-cancer Genetic Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Pan-cancer Genetic Testing Product Life Cycle
Figure 12. Global Pan-cancer Genetic Testing Revenue Share by Company in 2025
Figure 13. Pan-cancer Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Pan-cancer Genetic Testing Revenue in 2025
Figure 15. Value Chain Map of Pan-cancer Genetic Testing
Figure 16. Global Pan-cancer Genetic Testing Market PEST Analysis
Figure 17. Global Pan-cancer Genetic Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Pan-cancer Genetic Testing Market Share by Type
Figure 20. Market Share of Pan-cancer Genetic Testing by Type (2020-2025)
Figure 21. Global Pan-cancer Genetic Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pan-cancer Genetic Testing Market Share by Application
Figure 24. Global Pan-cancer Genetic Testing Market Share by Application (2020-2025)
Figure 25. Global Pan-cancer Genetic Testing Market Share by Application in 2024
Figure 26. Global Pan-cancer Genetic Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Pan-cancer Genetic Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Pan-cancer Genetic Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Pan-cancer Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Pan-cancer Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Pan-cancer Genetic Testing Market Share by Country in 2024
Figure 35. Germany Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Pan-cancer Genetic Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Pan-cancer Genetic Testing Market Size Market Share by Region in 2024
Figure 42. China Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Pan-cancer Genetic Testing Market Size and Growth Rate (M USD)
Figure 48. South America Pan-cancer Genetic Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Pan-cancer Genetic Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Pan-cancer Genetic Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Pan-cancer Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Pan-cancer Genetic Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Pan-cancer Genetic Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Pan-cancer Genetic Testing Market Share Forecast by Application (2026-2035)
